Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) EPS (Weighted Average and Diluted) (2021 - 2025)

Tenon Medical (TNON) has 5 years of EPS (Weighted Average and Diluted) data on record, last reported at -$515.42 in Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) fell 14098.99% year-over-year to -$515.42; the TTM value through Sep 2025 reached -$515.42, down 1438.58%, while the annual FY2024 figure was -$11.26, 83.6% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$515.42 in Q3 2025 per TNON's latest filing, down from -$0.36 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $7.34 in Q4 2024 and bottomed at -$13911.9 in Q4 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$1113.3, with a median of -$2.8 recorded in 2021.
  • Peak YoY movement for EPS (Weighted Average and Diluted): skyrocketed 102.75% in 2022, then tumbled 1806639.52% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$3.05 in 2021, then surged by 74.75% to -$0.77 in 2022, then crashed by 1806639.52% to -$13911.9 in 2023, then skyrocketed by 100.05% to $7.34 in 2024, then plummeted by 7122.11% to -$515.42 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$515.42 in Q3 2025, -$0.36 in Q2 2025, and -$1.01 in Q1 2025.